K.U.Leuven R&D

4AZA

Pharmaceutical preparations for the treatment and diagnosis of medical and surgical diseases; Medical health care products and pharmaceutical preparations for therapeutic and clinical use for the treatment of immune related diseases (i;e; organ transplantation and autoimmune diseases), infectious diseases, inflammatory diseases, genetic diseases and diseases of the central and peripheral nervous systems such as rheuma, rheumatoid arthritis, lupus erythematosus, multiple sclerosis, irritable Bowel Syndrome, spondyloarthropathy, psoriasis, Crohn's disease, Graft versus host disease, etc;Research and product development services concerning biotechnology and development of therapeutics and the collection, cataloging, and tracking of medical information, biochemical information, genetic information, or genomic or proteomic information in connection with the identification of individuals and biological samples suitable for research or clinical trials;

E-MEDIS

E MEDIS;Providing of food and drink; temporary accommodation; medical, hygienic and beauty care; veterinary and agricultural services; legal services; scientific and industrial research; computer programming; services that cannot be classified in other classes;

E-MEDIT

E MEDIT;Providing of food and drink; temporary accommodation; medical, hygienic and beauty care; veterinary and agricultural services; legal services; scientific and industrial research; computer programming; services that cannot be classified in other classes;

FURIN

biological , chemical, and enzyme preparations for medical and veterinary purposes, namely pharmaceutical preparations used in the treatment of mammals with enzyme insufficiency or deficiency; chemical reagents for medical and veterinary use, namely, clinical medical reagents; medical diagnostic reagents; medicines for human and veterinary purposes, namely, pharmaceutical preparations used in the treatment of mammals with enzyme insufficiency or deficiency;Genetically engineered animal cells for in vitro production for medical or veterinary use of biological active recombinant proteins or genetically engineered derivatives thereof using co-expression of a gene encoding a proprotein or precursor protein and a gene encoding a proprotein convertase, including genetically engineered animals for in vivo production for medical or veterinary use of biologically active recombinant proteins or genetically engineered derivatives thereof using co-expression of a gene encoding a proprotein or precursor protein and a gene encoding a proprotein convertase, test-tube manufacture for medical or veterinary use of biologically active recombinant proteins genetically engineered derivatives thereof from a proprotein or precursor protein using a proprotein convertase, biologically active recombinant proteins or genetically engineered derivatives of plasma proteins such as blood clotting factors and albumin, biological active recombinant proteins or genetically engineered derivatives of brain proteins such as neuropeptides, polypeptide hormones and receptors, biologically active recombinant proteins or genetically engineered derivatives of growth and differentiation factors such as for instance members of the TGF- BETA/BMP superfamily, biologically active recombinant proteins or genetically engineered derivatives of growth factor receptors such as the type I insulin-like growth factor receptor, biologically active recombinant proteins or genetically engineered derivatives of viral proteins from viruses, such as for example HIV, Ebola virus, Marburg virus, influenza virus, biologically active recombinant protein or genetically engineered derivatives of toxins e.g. anthrax toxin, biologically active recombinant proteins or genetically engineered derivatives of a variety of enzymes such as metalloproteinases and proprotein convertases, biologically active recombinant proteins or genetically engineered derivatives of several cell-surface receptors, adhesion molecules, signaling proteins and extracelluar-martix proteins, biologically active recombinant proteins or genetically engineered derivatives of proteins or fragments thereof for production of vaccines, biological active recombinant proteins or genetically engineered derivatives of any natural occurring of artificially designed proprotein or precursor protein which requires the action of a proprotein convertase for cleavage into biologically active components;Biological research, namely biomedical research, biochemical research, genetic research, animal cell biotechnology research, agricultural research, and viral research; blood bank services; research and development of new pharmaceutical and research products for others; Professional consultancy, namely, technical consultation in the field of biomedical research, biochemical research, genetic research, animal cell biotechnology research, agricultural research and viral research;

LEUVEN GENETICS

ANTIPARASITICS; BACTERIAL PREPARATIONS FOR MEDICAL AND VETERINARY USE; BACTERIOLOGICAL PREPARATIONS REPARATIONS FOR MEDICAL AND VETERINARY USE; BIOCIDES; BIOLOGICAL PREPARATIONS FOR MEDICAL PURPOSES; BIOLOGICAL PREPARATIONS FOR VETERINARY PURPOSES; CHEMICAL PREPARATIONS FOR MEDICAL PURPOSES, NAMELY COMBATING INFECTIONS, DISEASES OR THERAPEUTIC TREATMENT OF OTHER DISEASES; CHEMICAL PREPARATIONS FOR VETERINARY PURPOSES NAMELY, COMBATING INFECTION DISEASES OR THERAPEUTIC TREATMENT OF OTHER DISEASES; CHEMICAL REAGENTS FOR MEDICAL OR VETERINARY PURPOSES; CHEMICAL-PHARMACEUTICAL PREPARATIONS NAMELY, COMBATING INFECTION DISEASES OR THERAPEUTIC TREATMENT OF OTHER DISEASES; CULTURES OF MICRO-ORGANISMS FOR MEDICAL AND VETERINARY USE; DIAGNOSTIC PREPARATIONS FOR MEDICAL PURPOSES; ENZYME PREPARATIONS FOR MEDICAL PURPOSES; ENZYME PREPARATIONS FOR VETERINARY PURPOSES; ENZYMES FOR MEDICAL PURPOSES; ENZYMES FOR VETERINARY PURPOSES; FUNGICIDES; GERMICIDES; HERBICIDES; HORMONES FOR MEDICAL PURPOSES; INSECTICIDES; PREPARATIONS OF MICRO-ORGANISMS FOR MEDICAL AND VETERINARY USE; PESTICIDES; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INFECTION DISEASES, DIABETES, NEURODEGENERATIVE DISEASES, METABOLIC DISORDERS; VETERINARY PREPARATIONS FOR BOVINE, SHEEP, HORSE, PIG, RABBIT, GOAT, CHICKEN, DOG, CAT;AGRICULTURAL CHEMICALS, EXCEPT FUNGICIDES, WEED KILLERS, HERBICIDES, INSECTICIDES AND PARASITICIDES, NAMELY PLANT FERTILIZERS AND SOIL CONDITIONERS; BIOCHEMICAL CATALYSTS FOR USE IN THE PRODUCTION OF SMALL BIOCHEMICAL MOLECULES OR PROTEINS; CHEMICAL PREPARATIONS FOR SCIENTIFIC PURPOSES, NAMELY, PROPRIETARY REAGENTS, MICRO-ARRAYS, OLIGONUCLEOTIDES ENZYMES, DNA PREPARATIONS AND REAGENT MIXTURES FOR USE IN GENOME-WIDE MAPPING TECHNOLOGIES; CHEMICAL REAGENTS FOR SCIENTIFIC USE; CULTURES OF MICRO-ORGANISMS FOR SCIENTIFIC USE; ENZYME PREPARATIONS FOR INDUSTRIAL PURPOSES; CULTURES OF MICRO-ORGANISMS FOR SCIENTIFIC PURPOSES; PREPARATIONS OF MICRO-ORGANISMS, FOR SCIENTIFIC USE; PLANT GROWTH REGULATING PREPARATIONS FOR AGRICULTURAL USE, CHEMICAL PREPARATIONS FOR THE MANUFACTURE OF PHARMACEUTICALS;GENETICS;BACTERIOLOGICAL RESEARCH; BACTERIOLOGY; BIOLOGICAL RESEARCH; CHEMICAL ANALYSIS; CHEMICAL RESEARCH, CHEMISTRY CONSULTATION; COMPUTER SOFTWARE DESIGN; LICENSING OF INTELLECTUAL PROPERTY; MAINTENANCE OF COMPUTER SOFTWARE; PATENT EXPLOITATION; RESEARCH AND DEVELOPMENT FOR NEW PRODUCTS FOR OTHERS, TECHNICAL RESEARCH IN THE FIELD OF BIOLOGY AND MEDICINE, LEASING ACCESS TIME TO A COMPUTER DATA BASE IN THE FIELD OF MEDICINAL AND (MOLECULAR) BIOLOGICAL DATA;

SOLFIBREAD

Bakery products; bran; bread; bread products, namely, bread products with high soluble fibre content made using mixtures of wheat, rye, barley and/or oat milling products and/or enzyme technology and/or by addition of soluble fibre containing material; cereals and cereal preparations; flour; flour concentrates; flour-based products, namely, bread products with high soluble fibre content made using mixtures of wheat, rye, barley and/or oat milling products and/or enzyme technology and/or by addition of soluble fibre containing material; flour-milling products, namely, bread products with high soluble fibre content made using mixtures of wheat, rye, barley and/or oat milling products and/or enzyme technology and/or by addition of soluble fibre containing material; pastries, cakes, biscuits; prepared baking mixes;dietary and nutritional supplements; dietary food supplements; dietary supplements; food for babies;